A nurse is caring for a client who has bulimia nervosa has a new prescription for a selective serotonin reuptake inhibitor (SSRI). Which of the following medications should the nurse anticipate administering?

A. Valproate. Valproate is an anticonvulsant medication primarily used to treat seizures and bipolar disorder, and it is not indicated for the treatment of bulimia nervosa. B. Olanzapine. Olanzapine is an atypical antipsychotic that may be used in certain eating disorders, but it is not the first-line treatment for bulimia nervosa. SSRIs, specifically fluoxetine, are more commonly prescribed for this condition. C. Naltrexone. Naltrexone is an opioid antagonist used primarily for alcohol dependence and opioid use disorder. It is not indicated for the treatment of bulimia nervosa. D. Fluoxetine. Fluoxetine is a selective serotonin reuptake inhibitor (SSRI) that has been shown to be effective in reducing binge-eating and purging behaviors in individuals with bulimia nervosa. It is the medication the nurse should anticipate administering for this client.